MARY VERRINDER: Open Payments
NPI 1760994107 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 9 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $226 · 2025 $212
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $50 |
| Imperative Care, Inc | 1 | $41 |
| ABIOMED | 1 | $29 |
| Boston Scientific Corporation | 1 | $24 |
| CARDIVA MEDICAL, INC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| CORDIS US CORP. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AMPLATZER AMULET, SYMPHONY CATHETER, FARAPULSE, CARDIVA VASCADE MVP VVCS 6-12F, LEQVIO.
Industry payments across NJ — which companies pay providers there.
